Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential use of SU-5416 as a radiosensitizer in cancer therapy

Oct. 17, 2002

Neurological benefits with motexafin gadolinium in cancer patients with brain metastases

Oct. 17, 2002

IDM and Epimmune enter license option agreement

Oct. 17, 2002

Orphan drug grant will help defray the costs of clinical studies with MTC-DOX

Oct. 16, 2002

WX-UK1 enters first clinical trial in cancer patients

Oct. 16, 2002

Mercian and Eisai describe the isolation of new antiangiogenic agents from fungal cultures

Oct. 16, 2002

MMP inhibitors for use in cancer, COPD, asthma and brain edema prepared at Novartis

Oct. 15, 2002

Initiation of phase II Triapine trial in head and neck cancer

Oct. 14, 2002

IL-21 added to ZymoGenetics development pipeline

Oct. 14, 2002

Viventia options anticancer hybridomas from M.D. Cancer Center

Oct. 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...